Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem Transplantation in AL Amyloidosis
NCT00075621Phase 2Completed
- Sponsor
- Boston Medical Center
- Start
- Aug 2000
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of melphalan in amyloid light chain amyloidosis, sponsored by Boston Medical Center. Primary endpoint: Safety and Tolerability. Started Aug 2000; status: completed.
02
Drugs
melphalan
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT00075621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075621.